Recall Register

Food, drugs, devices › GE Healthcare, LLC

Device recall: GE Healthcare, Xeleris 2 Processing & Review Workstation. The display, processing, archiving, and communication of data

FDA enforcement event 64804 · Class II · initiated 6 Oct 2011 · status Terminated · terminated 4 Feb 2014

DeviceVoluntary: Firm initiated1 product recordWaukesha, WI

FDA enforcement event 64804 is a device recall by GE Healthcare, LLC of Waukesha, WI, initiated 6 Oct 2011 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 114 device enforcement events initiated in 2011 carry the same class.

Status: Terminated, terminated 4 Feb 2014. Initiation: voluntary: firm initiated. GE Healthcare, LLC has 225 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

GE Healthcare, LLC, Waukesha, WI.

Reason for recall

"GE Healthcare has become aware of a software issue in your Xeleris 2.1 workstation (that is used for processing Discovery 530/570 data), that may impact patient safety. On imported CT scans, Myocardial Perfusion Imaging (MPI) studies may create artifacts in attenuation corrected images. This may lead to a potential for misdiagnosis."

Distribution

"Worldwide Distribution - USA including GA, and NY; and countries of: Canada, Israel, Italy and Switzerland."

Product records

Recall numberProductQuantityClassStatusReport date
Z-1164-2013GE Healthcare, Xeleris 2 Processing & Review Workstation. The display, processing, archiving, and communication of data acquired by Emission Tomography cameras used in diagnostic radiology, including procedures for planar imaging, whole body imaging, tomographic (SPECT) imaging, positron imaging by coincidence,…11Class IITerminated1 May 2013

Context

89%of 2011 device events are Class II114 events that year
1product record in this eventfirm median: 1
225events on this register for the firm

Other enforcement events for GE Healthcare, LLC

InitiatedProduct (first record)TypeClassRecords
27 Feb 2026SIGNA Premier systemsDeviceClass II1
15 Jul 2022(1) GE Centricity Universal Viewer 6.0, Model 2088026-9XX; (2) GE Centricity Universal Viewer 7.0, Model 5826659-0XX; (3DeviceClass II1
24 Jun 2022SIGNA Premier magnetic resonance scanner, model 5748519.DeviceClass II1
14 Jun 2022Centricity PACS Software Version 7.0 SP0.0.4.7DeviceClass II1
8 Jun 2022GE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images and data withinDeviceClass II1
2 Jun 2022Service manuals for the CT, PET, or NM table as follows: GT1700/GT1700V/VT1700, GT2000/VT2000, GT2000x/VT2000x, High CapDeviceClass II1
1 Jun 2022GE Healthcare Aisys CS2 Anesthesia System, Part number 1011-9050-000; and Avance CS2 and Avance CS2 Pro Anesthesia SysteDeviceClass I1
27 May 2022GE Healthcare Avance CS2, Avance CS2 Pro Anesthesia Systems, Part #1009-9050-000; and Aisys CS2 Anesthesia Systems, PartDeviceClass II1
10 May 2022CARESCAPE Central Station (CSCS) V2, Model numbers 2082278-001 and 2082279-001. Update 3/10/2023: The following FRU and DeviceClass II1
28 Apr 2022Centricity Universal Viewer Zero Footprint ClientDeviceClass II5

All 225 events for GE Healthcare, LLC

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "GE Healthcare has become aware of a software issue in your Xeleris 2.1 workstation (that is used for processing Discovery 530/570 data), that may impact patient safety. On imported CT scans, Myocardial Perfusion Imaging (MPI) studies may create artifacts in attenuation corrected images. This may lead to a potential for misdiagnosis."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - USA including GA, and NY; and countries of: Canada, Israel, Italy and Switzerland."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 4 Feb 2014. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.